Developer docs
API playgroundTry for free, no card

Search company profiles

StudyKIK

Full company profile

uuid0006qxq

Namestring
StudyKIK
Legal namestring
Caerus Marketing Group, LLC
Websiteurl
studykik.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

StudyKIK (legal entity: Caerus Marketing Group, LLC) is a full-service patient recruitment and retention technology company serving the clinical trial industry. Founded in 2013 and acquired by Syneos Health (a global CRO), StudyKIK operates as a Syneos Health Company headquartered in Costa Mesa, California, with 101–250 employees. The company runs an enterprise field sales motion to pharmaceutical sponsors while providing a self-serve platform to clinical trial sites, and a direct-to-consumer patient discovery experience on studykik.com.

The platform is modular and centers on the KIKsite site portal for tracking patient progress, managing email/text/video communications, IRB ad creation, and media source tracking. Sponsor-facing modules include Study Websites (with multilingual capabilities and a 24/7 global call center), eConsent (electronic informed consent powered by DocuSign, compliant with ESIGN, UETA, HIPAA, and Title 21 CFR Part 11), Study Companion Apps (eDiary, ePRO, medication reminders, in-app video visits, Uber Health integration, patient payments), Trial Reporting (central study dashboard aggregating recruitment, consent, randomization, and retention data), and CarePackage (end-to-end patient experience platform). Virtual Visits enable live video appointments from any smart device without additional software. The company also offers Enrollment Plans — quote-based, per-study patient referrals tailored to site budgets and enrollment goals.

StudyKIK generates revenue through technology platform subscriptions and per-study service agreements with sponsors and sites, on a subscription/recurring basis with quote-based pricing rather than publicly listed tiers. Named sponsor logos displayed on the patient-facing site include Genentech, Merck, Exact Sciences, and Ingeneron. The company is privately held, with no disclosed VC/PE backing beyond a 2018 Kinderhook Industries event, and operates without a public ticker.

Short descriptiontext

StudyKIK is a clinical trial patient recruitment and retention technology company serving pharmaceutical sponsors, clinical trial sites, and patients. Its modular platform spans eConsent (DocuSign-powered), companion apps, virtual visits, and central reporting, operating as a subsidiary of CRO Syneos Health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSanta Monica, United States
HQ citystring
Santa Monica
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, patient retention software, eConsent platform, clinical trial technology, patient engagement apps
Industry2 codes
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Patient Recruitment & Retention Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Technology Platform Subscriptions
TypeSubscription Recurring
Description

StudyKIK provides a technology platform for clinical trial patient recruitment and retention. The platform includes site tools (KIKsite portal), sponsor solutions (eConsent, study websites, apps, reporting), and patient-facing services. Revenue is generated through service agreements with clinical trial sites and sponsors, likely on a subscription or per-study basis.

studykik.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

StudyKIK provides a cloud-based patient recruitment and retention technology platform for clinical trials, connecting pharmaceutical sponsors, research sites, and patients. Its core offering is the KIKsite site portal complemented by sponsor-side tools including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting dashboards, Virtual Visits, and the CarePackage patient support platform. The company sells custom-tailored enrollment plans and recruitment services to clinical trial sites and sponsors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Start recruiting qualified patients in as little as 24 hours with no long-term contracts
+2 more records
Product overview1 text field

StudyKIK is a full-service patient recruitment and retention technology company offering an integrated platform with a modular architecture. The core offering centers on the KIKsite Platform for sites to manage patient recruitment, tracking, and communications, complemented by sponsor-facing solutions including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting, and CarePackage. Additional services include Virtual Visits for remote trial participation and custom Enrollment Plans. The platform connects clinical trial sponsors, research sites, and patients to accelerate enrollment timelines.

Product and service9 records
1Patient Recruitment
CategoryPatient Recruitment Services
Description

Custom-tailored patient recruitment service helping clinical trial sites start recruiting qualified patients in as little as 24 hours with no long-term contracts; designed for clinical research sites that need to fill enrollment quotas.

2KIKsite Platform
CategoryClinical Trial Site Software
Description

All-in-one site portal for clinical trial sites that tracks patient progress, manages communications via email/text/video, supports direct scheduling, IRB ad creation, patient database management, and media source tracking with real-time analytics.

3Virtual Visits
CategoryTelemedicine / Virtual Trial Visits
Description

Live video visit capability enabling clinical trial sites to conduct remote appointments from any smart device without additional software, available 24 hours a day, designed to improve accessibility and reduce patient and site burden.

4Study Websites
CategoryPatient Recruitment Websites
Description

Custom-made, mobile-friendly clinical trial websites that educate potential participants about a study and accelerate enrollment, with multilingual content, global call center support, and Google Analytics reporting.

5eConsent
CategoryElectronic Consent Software
Description

Electronic informed consent platform developed with real patients and sites that lets patients review and sign consent documents digitally using interactive multimedia, video chat, and live note collaboration; powered by DocuSign and compliant with ESIGN, UETA, HIPAA and Title 21 CFR Part 11.

6Study Companion Apps
CategoryPatient Engagement Mobile Apps
Description

Custom-tailored mobile apps for clinical trial patients that include eDiary, ePRO, medication reminders, in-app video visits, surveys, achievements, Uber Health transportation integration, and patient payment integration to improve engagement and retention.

7Trial Reporting
CategorySponsor Analytics Dashboard
Description

Central study dashboard that aggregates recruitment, consent, randomization, and retention data across multiple sites, giving sponsors real-time enrollment tracking and site performance metrics with customized reporting and analytics.

8CarePackage
CategoryPatient Support Platform
Description

Comprehensive patient support platform designed to enhance every step of the clinical trial journey for sponsors, providing compassionate and connected patient experiences throughout the study.

9Enrollment Plans
CategoryPatient Referral Plans
Description

Budget and enrollment goal-based plans for clinical trial sites that deliver qualified patient referrals, tailored to site needs with no long-term contracts.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1DocuSign
Strategic tierCoreTypeTechnology or Integration
Description

StudyKIK's eConsent platform is powered by DocuSign, enabling patients to electronically sign consent documents in full compliance with ESIGN, UETA, HIPAA and Title 21, CFR Part 11 regulations.

studykik.com
Strategic tierCoreTypeOthers
Description

StudyKIK is owned and operated by Caerus Marketing Group LLC d/b/a StudyKIK, a Syneos Health Company. Syneos Health is a global pharmaceutical solutions organization that provides contract research and commercialization services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Antidote (formerly TrialReach)
TypeDirect peer
Description

Antidote is a digital clinical trial patient recruitment platform connecting sponsors and patients via online matching and outreach. It is a direct competitor to StudyKIK in the same product category with comparable sponsor/site/patient value proposition.

TypeDirect peer
Description

BBK Worldwide is a long-standing patient recruitment and engagement agency for clinical trials, offering digital and traditional recruitment tactics plus site support. It competes head-to-head with StudyKIK for sponsor recruitment budgets across therapeutic areas.

3Deep 6 AI
TypeEmerging player
Description

Deep 6 AI applies AI to EHR data to identify and match patients to clinical trials. It is an emerging competitor focused on a differentiated AI-driven targeting approach that intersects with StudyKIK's recruitment offering.

TypeEmerging player
Description

SubjectWell is a patient recruitment platform that connects clinical trial sponsors with treatment-naive patients via consumer channels. It is an emerging player in the same recruitment category with overlap on direct-to-patient acquisition.

TypeBroad incumbent
Description

Acurian, part of PPD (now Thermo Fisher), provides patient recruitment and retention services as part of a full-service CRO offering. It is a broad incumbent competing with StudyKIK for sponsor recruitment budgets, but bundled within a much wider CRO portfolio.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with patient recruitment capabilities embedded across its full-service and tech offerings. As a broad incumbent it overlaps with StudyKIK for sponsor budgets and could choose to displace third-party platforms with internal solutions.

TypeBroad incumbent
Description

Parexel is a major global CRO with site and patient recruitment capabilities across its clinical trial services portfolio. It competes with StudyKIK indirectly through bundled CRO contracts and could develop or acquire competing recruitment technology.

TypeBroad incumbent
Description

Medpace is a mid-to-large CRO offering full-service clinical development including site management and patient recruitment. It competes with StudyKIK primarily through its integrated CRO delivery model rather than a standalone recruitment platform.

TypeOthers
Description

Large academic medical centers operate proprietary trial-matching platforms (e.g., Partners/i2b2-derived) that compete with StudyKIK for patient identification within their health systems. They are adjacent ecosystem participants rather than direct commercial competitors.

TypeOthers
Description

CenterWatch is a long-running clinical trial information and patient-recruitment services provider publishing trial listings and operating sponsor-facing services. It is thematically related as a patient-discovery channel but operates at smaller scale and a different business model than StudyKIK.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses2 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

StudyKIK

Clinical Trial Patient Recruitment & Retention Softwarestudykik.com

StudyKIK is a clinical trial patient recruitment and retention technology company serving pharmaceutical sponsors, clinical trial sites, and patients. Its modular platform spans eConsent (DocuSign-powered), companion apps, virtual visits, and central reporting, operating as a subsidiary of CRO Syneos Health.

What StudyKIK does

StudyKIK (legal entity: Caerus Marketing Group, LLC) is a full-service patient recruitment and retention technology company serving the clinical trial industry. Founded in 2013 and acquired by Syneos Health (a global CRO), StudyKIK operates as a Syneos Health Company headquartered in Costa Mesa, California, with 101–250 employees. The company runs an enterprise field sales motion to pharmaceutical sponsors while providing a self-serve platform to clinical trial sites, and a direct-to-consumer patient discovery experience on studykik.com.

The platform is modular and centers on the KIKsite site portal for tracking patient progress, managing email/text/video communications, IRB ad creation, and media source tracking. Sponsor-facing modules include Study Websites (with multilingual capabilities and a 24/7 global call center), eConsent (electronic informed consent powered by DocuSign, compliant with ESIGN, UETA, HIPAA, and Title 21 CFR Part 11), Study Companion Apps (eDiary, ePRO, medication reminders, in-app video visits, Uber Health integration, patient payments), Trial Reporting (central study dashboard aggregating recruitment, consent, randomization, and retention data), and CarePackage (end-to-end patient experience platform). Virtual Visits enable live video appointments from any smart device without additional software. The company also offers Enrollment Plans — quote-based, per-study patient referrals tailored to site budgets and enrollment goals.

StudyKIK generates revenue through technology platform subscriptions and per-study service agreements with sponsors and sites, on a subscription/recurring basis with quote-based pricing rather than publicly listed tiers. Named sponsor logos displayed on the patient-facing site include Genentech, Merck, Exact Sciences, and Ingeneron. The company is privately held, with no disclosed VC/PE backing beyond a 2018 Kinderhook Industries event, and operates without a public ticker.

StudyKIK firmographics

Firmographics
Name
StudyKIK
Legal name
Caerus Marketing Group, LLC
Website
https://studykik.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
StudyKIK is a clinical trial patient recruitment and retention technology company serving pharmaceutical sponsors, clinical trial sites, and patients. Its modular platform spans eConsent (DocuSign-powered), companion apps, virtual visits, and central reporting, operating as a subsidiary of CRO Syneos Health.
Ownership category
akta.pro rank

StudyKIK industry classification

Industry
Product category
Clinical Trial Patient Recruitment & Retention Software
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGACAE
Clinical Trial Site Operations & Study Coordination

Keywords

  • Clinical trial recruitment
  • Patient retention software
  • EConsent platform
  • Clinical trial technology
  • Patient engagement apps

Where StudyKIK is headquartered

Location

Headquarters

HQ city
Santa Monica
HQ country
United States
HQ region
North America

Offices1 record

Markets served

StudyKIK business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Technology Platform Subscriptions: StudyKIK provides a technology platform for clinical trial patient recruitment and retention. The platform includes site tools (KIKsite portal), sponsor solutions (eConsent, study websites, apps, reporting), and patient-facing services. Revenue is generated through service agreements with clinical trial sites and sponsors, likely on a subscription or per-study basis.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

StudyKIK product offering

Product offering

Core offering

StudyKIK provides a cloud-based patient recruitment and retention technology platform for clinical trials, connecting pharmaceutical sponsors, research sites, and patients. Its core offering is the KIKsite site portal complemented by sponsor-side tools including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting dashboards, Virtual Visits, and the CarePackage patient support platform. The company sells custom-tailored enrollment plans and recruitment services to clinical trial sites and sponsors.

Product overview

StudyKIK is a full-service patient recruitment and retention technology company offering an integrated platform with a modular architecture. The core offering centers on the KIKsite Platform for sites to manage patient recruitment, tracking, and communications, complemented by sponsor-facing solutions including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting, and CarePackage. Additional services include Virtual Visits for remote trial participation and custom Enrollment Plans. The platform connects clinical trial sponsors, research sites, and patients to accelerate enrollment timelines.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Recruitment Custom-tailored patient recruitment service helping clinical trial sites start recruiting qualified patients in as little as 24 hours with no long-term contracts; designed for clinical research sites that need to fill enrollment quotas.
  • KIKsite Platform All-in-one site portal for clinical trial sites that tracks patient progress, manages communications via email/text/video, supports direct scheduling, IRB ad creation, patient database management, and media source tracking with real-time analytics.
  • Virtual Visits Live video visit capability enabling clinical trial sites to conduct remote appointments from any smart device without additional software, available 24 hours a day, designed to improve accessibility and reduce patient and site burden.
  • Study Websites Custom-made, mobile-friendly clinical trial websites that educate potential participants about a study and accelerate enrollment, with multilingual content, global call center support, and Google Analytics reporting.
  • eConsent Electronic informed consent platform developed with real patients and sites that lets patients review and sign consent documents digitally using interactive multimedia, video chat, and live note collaboration; powered by DocuSign and compliant with ESIGN, UETA, HIPAA and Title 21 CFR Part 11.
  • Study Companion Apps Custom-tailored mobile apps for clinical trial patients that include eDiary, ePRO, medication reminders, in-app video visits, surveys, achievements, Uber Health transportation integration, and patient payment integration to improve engagement and retention.
  • Trial Reporting Central study dashboard that aggregates recruitment, consent, randomization, and retention data across multiple sites, giving sponsors real-time enrollment tracking and site performance metrics with customized reporting and analytics.
  • CarePackage Comprehensive patient support platform designed to enhance every step of the clinical trial journey for sponsors, providing compassionate and connected patient experiences throughout the study.
  • Enrollment Plans Budget and enrollment goal-based plans for clinical trial sites that deliver qualified patient referrals, tailored to site needs with no long-term contracts.

Quantifiable outcome

  • Start recruiting qualified patients in as little as 24 hours with no long-term contracts
  • +2 more outcomes

Companies that use StudyKIK

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

StudyKIK technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

StudyKIK partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • DocuSigncoreTechnology or IntegrationStudyKIK's eConsent platform is powered by DocuSign, enabling patients to electronically sign consent documents in full compliance with ESIGN, UETA, HIPAA and Title 21, CFR Part 11 regulations.
  • Syneos HealthcoreOthersStudyKIK is owned and operated by Caerus Marketing Group LLC d/b/a StudyKIK, a Syneos Health Company. Syneos Health is a global pharmaceutical solutions organization that provides contract research and commercialization services.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

StudyKIK competitors and assessment

Company assessment

Direct peers

  • Antidote (formerly TrialReach): Antidote is a digital clinical trial patient recruitment platform connecting sponsors and patients via online matching and outreach. It is a direct competitor to StudyKIK in the same product category with comparable sponsor/site/patient value proposition.
  • BBK Worldwide: BBK Worldwide is a long-standing patient recruitment and engagement agency for clinical trials, offering digital and traditional recruitment tactics plus site support. It competes head-to-head with StudyKIK for sponsor recruitment budgets across therapeutic areas.

Emerging players

  • Deep 6 AI: Deep 6 AI applies AI to EHR data to identify and match patients to clinical trials. It is an emerging competitor focused on a differentiated AI-driven targeting approach that intersects with StudyKIK's recruitment offering.
  • SubjectWell: SubjectWell is a patient recruitment platform that connects clinical trial sponsors with treatment-naive patients via consumer channels. It is an emerging player in the same recruitment category with overlap on direct-to-patient acquisition.

Broad incumbents

  • Acurian (PPD/Thermo Fisher): Acurian, part of PPD (now Thermo Fisher), provides patient recruitment and retention services as part of a full-service CRO offering. It is a broad incumbent competing with StudyKIK for sponsor recruitment budgets, but bundled within a much wider CRO portfolio.
  • IQVIA: IQVIA is the world's largest CRO with patient recruitment capabilities embedded across its full-service and tech offerings. As a broad incumbent it overlaps with StudyKIK for sponsor budgets and could choose to displace third-party platforms with internal solutions.
  • Parexel International: Parexel is a major global CRO with site and patient recruitment capabilities across its clinical trial services portfolio. It competes with StudyKIK indirectly through bundled CRO contracts and could develop or acquire competing recruitment technology.
  • Medpace: Medpace is a mid-to-large CRO offering full-service clinical development including site management and patient recruitment. It competes with StudyKIK primarily through its integrated CRO delivery model rather than a standalone recruitment platform.

Others

  • Mass General Brigham / Partners HealthCare Clinical Trial Platforms: Large academic medical centers operate proprietary trial-matching platforms (e.g., Partners/i2b2-derived) that compete with StudyKIK for patient identification within their health systems. They are adjacent ecosystem participants rather than direct commercial competitors.
  • CenterWatch: CenterWatch is a long-running clinical trial information and patient-recruitment services provider publishing trial listings and operating sponsor-facing services. It is thematically related as a patient-discovery channel but operates at smaller scale and a different business model than StudyKIK.

Market position

Strengths2 records

Weaknesses2 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

StudyKIK social profiles

Digital presence

StudyKIK compliance and trust

Trust signal

Compliance2 records

StudyKIK financial estimates

Financial estimate

Revenue estimate

Valuation estimate

StudyKIK leadership team

Management profile

Number of profiles

Profiles2 records

StudyKIK funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

StudyKIK M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about StudyKIK

What does StudyKIK do?

StudyKIK provides a cloud-based patient recruitment and retention technology platform for clinical trials, connecting pharmaceutical sponsors, research sites, and patients. Its core offering is the KIKsite site portal complemented by sponsor-side tools including Study Websites, eConsent (powered by DocuSign), Study Companion Apps, Trial Reporting dashboards, Virtual Visits, and the CarePackage patient support platform. The company sells custom-tailored enrollment plans and recruitment services to clinical trial sites and sponsors.

Is StudyKIK a public or private company?

StudyKIK is a private company. It is classified as corporate owned and is currently operating.

When was StudyKIK founded?

StudyKIK was founded in 2013. It employs 51 to 100 people.

Where is StudyKIK based?

StudyKIK is headquartered in Santa Monica, United States, in the North America region.

How does StudyKIK make money?

One revenue line is on record: technology Platform Subscriptions.

Who are StudyKIK's main competitors?

Direct peers on record are Antidote (formerly TrialReach) and BBK Worldwide. Emerging players are Deep 6 AI and SubjectWell. Broad incumbents are Acurian (PPD/Thermo Fisher), IQVIA, Parexel International and Medpace. Others are Mass General Brigham / Partners HealthCare Clinical Trial Platforms and CenterWatch.

Does StudyKIK have an API?

No public API is recorded for StudyKIK.

What industry is StudyKIK in?

StudyKIK's product category is Clinical Trial Patient Recruitment & Retention Software. Its primary akta.pro industry code is HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 54169 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireSyneos Health Reports Third Quarter 2021 ResultsSyneos Health reported Q3 2021 revenue of $1,348.2 million, up 22.7% year-over-year, and GAAP net income of $78.2 million, up 23.4%. Clinical Solutions net new business awards grew 35% to $1,353.8 million, and backlog increased 22.3% to $11,281.4 million. The company also closed acquisitions of StudyKIK and RxDataScience.BioSpaceSyneos Health Acquires StudyKIKAcquisition Offers Sites and Sponsors Access to Technology-Enabled, Insight-Powered Solutions, Accelerating Clinical Trial Recruitment, Retention and DiversitySyneos Health acquired StudyKIK, a technology-enabled clinical trial recruitment and retention company. The acquisition adds capabilities to accelerate patient enrollment and retention, with StudyKIK's platform having improved enrollment timelines by up to 94% and reduced start-up times by up to 75%.GlobeNewswireSyneos Health Acquires StudyKIKSyneos Health acquired StudyKIK, a clinical trial recruitment and retention company, to enhance its technology-enabled solutions. StudyKIK's platform has improved enrollment timelines by up to 94% and reduced start-up times by up to 75%, managing over 1,000 patient community groups. The acquisition expands Syneos Health's portfolio of patient-direct solutions.GlobeNewswireSyneos Health Acquires StudyKIKSyneos Health acquired StudyKIK, a clinical trial recruitment and retention company, on Sept. 14, 2021. StudyKIK's platform has improved enrollment timelines by up to 94% and reduced start-up times by up to 75%, managing over 1,000 patient community groups. The acquisition expands Syneos Health's portfolio of patient-direct, technology-enabled solutions.Seeking AlphaSyneos Health acquires clinical trial recruitment company StudyKIKSyneos Health acquired clinical trial recruitment company StudyKIK on September 14, 2021. The financial terms of the deal were not disclosed. The acquisition expands Syneos' portfolio of patient-direct, technology-enabled solutions.PrwebStudyKIK Launches Patient Oriented Direct Scheduling Service with Transportation Concierge for Clinical TrialsStudyKIK launched a direct scheduling service for over 3,600 research sites, with a transportation concierge to support study visits. The service aims to reduce no-show rates, which have dropped over 65% since launch, and is available for all trials supported by StudyKIK.PrwebStudyKIK Announces New Mobile Study Application for Patients in Clinical Trials to Revolutionize Patient Engagement & Retention During Study ParticipationStudyKIK announced a new mobile application for patients in clinical trials, designed to improve engagement and retention. The app claims up to 73% increase in study retention and over 200% increase in engagement, integrating with its MyStudyKIK portal. It is available on iOS and Android and complies with HIPAA and GDPR.PR NewswireSCRS Welcomes StudyKIK to the Global Impact Partner ProgramThe Society for Clinical Research Sites (SCRS) announced that StudyKIK has joined its Global Impact Partner (GIP) Program, a partnership that demonstrates StudyKIK's commitment to supporting clinical research sites. StudyKIK provides social media-based patient recruitment solutions for clinical trials and currently serves over 1,600 research sites. SCRS represents over 9,500 sites in 47 countries and sees this partnership as expanding engagement with the company.